newsfilter
← Latest News
GlobeNewswire·

Relmada Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025

CORAL GABLES, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (NASDAQ:RLMD, "Relmada", or "the Company")), a clinical-stage biotechnology company committed to advancing innovative breakthrough